MIDLAND, Mich., Sept. 30, 2026 – Dow (NYSE: DOW), a global materials science company, will showcase its expanding portfolio of pharmaceutical solutions at CPHI Milan 2026, one of the industry's largest global events, taking place Oct. 6-8, in Milan, Italy. Visitors can meet Dow experts to learn how the company's technologies help accelerate innovation and address evolving industry needs across pharmaceutical formulation development, processing, packaging and medical devices.
“Pharmaceutical manufacturers continue to face increasing pressure to accelerate launch of better therapeutic solutions maintaining efficiency and product safety,” said Dr. Isabel Almiro do Vale, global pharma platform growth director at Dow. “Dow's portfolio, technical expertise and dependable supply capabilities can help customers address the challenges across the pharmaceutical value chain and provide the necessary treatment to patients around the world.”
Featured technologies from Dow at CPHI 2026
- TERGITOL™ SENTRY™ 15-S-9 Surfactant: Dow’s new, high-purity, specialty-grade nonionic surfactant developed for biopharmaceutical manufacturing processes, including cell lysis and viral inactivation applications. Manufactured under GMP conditions and readily biodegradable.
- Topical formulation research: Dow will present new data demonstrating enhanced transdermal delivery of ibuprofen using CARBOWAX™ SENTRY™ PEG. Univar Solutions will showcase a formulation concept developed using this technology, highlighting its potential for topical drug delivery applications.
- Advanced medical and pharmaceutical plastic materials: Polymer innovations for packaging and medical devices, including blow-fill-seal (BFS) applications, lightweight pharmaceutical bottles and PVC-free medical films.
- Silicone solutions for healthcare: Building on nearly 80 years as a leader in the silicones industry, Dow is expanding engagement with pharmaceutical and healthcare customers to explore new opportunities for silicone innovation across formulation, processing and device applications.
“Evolving healthcare trends are creating new opportunities for innovation, and we believe the future of healthcare will require both proven technologies and new approaches.” said Joyce Liu, global strategic marketing director for healthcare, performance silicones. “CPHI Milan provides an opportunity to engage with the industry, listen to customers and explore how Dow can help address emerging challenges and support innovation across healthcare applications."
Dow scientists, technical specialists and commercial leaders will be available throughout the event to discuss applications, share technical expertise and explore collaboration opportunities.
Visit Dow at Booth 1B116 during CPHI Milan 2026.
About Dow
Dow (NYSE: DOW) is one of the world’s leading materials science companies, serving customers in high-growth markets such as packaging, infrastructure, mobility and consumer applications. Our global breadth, asset integration and scale, customer-focused innovation and leading business positions enable us to achieve profitable growth and help deliver a sustainable future. We operate manufacturing sites in 29 countries and employed approximately 34,600 people as of year-end 2025. Dow delivered sales of approximately $40 billion in 2025. References to Dow or the Company mean Dow Inc. and its subsidiaries. Learn more about us at www.dow.com.
For further information, please contact:
Stefanie DeLeeuw
+1 630 677 5984
sdeleeuw@dow.com